Praziquantel
Quinoline Derivatives and Related Substances
- Drug class
- Quinoline Derivatives and Related Substances
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 25
Overview
Plain-language summary, compiled from the cited regulatory records
Praziquantel is a medication belonging to the quinoline derivatives and related substances drug class [1]. It is approved for treating certain parasitic worm infections in patients aged 1 year and older [1]. Specifically, praziquantel is indicated for schistosomiasis caused by all species of schistosoma, including *Schistosoma mekongi*, *Schistosoma japonicum*, *Schistosoma mansoni*, and *Schistosoma hematobium* [1]. It is also approved for clonorchiasis and opisthorchiasis, which are infections caused by liver flukes such as *Clonorchis sinensis* and *Opisthorchis viverrini* [1].
In the past 12 months, there have been 25 adverse event reports associated with praziquantel [2]. The most frequently reported issues in these reports include off-label use, hypokalemia, product prescribing issues, use in unapproved indications, and reports of the drug being ineffective [2]. Praziquantel is available under various brand names [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | February 28, 2024 |
USUnited States· FDA
1 product
Uses
1 INDICATIONS AND USAGE Praziquantel tablets are indicated in patients aged 1 year and older for the treatment of the following infections: Schistosomiasis due to all species of schistosoma (for example, Schistosoma mekongi, Schistosoma japonicum, Schistosoma mansoni and Schistosoma hematobium ), and Clonorchiasis and Opisthorchiasis due to the liver flukes, Clonorchis sinensis/Opisthorchis viverrini (approval of this indication was based on studies in which the two species were not differentiated) Praziquantel tablets are an anthelmintic indicated in patients aged one year and older for the treatment of the following infections: Schistosomiasis due to all species of schistosoma (for example , Schistosoma mekongi , Schistosoma japonicum , Schistosoma mansoni and Schistosoma hematobium ), and, Clonorchiasis and Opisthorchiasis due to the liver flukes, Clonorchis sinensis and Opisthorchis viverrini
Drug interactions
Known interactions involving Praziquantel. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 16f2b9c4-a260-4a… · revised February 28, 2024 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.